We further performed cumulative meta-analyses to determine the stability of VEGF-C expression for survival in BC patients (Fig 5 and Fig 6).With inclusions of studies that patient number more than 70, the pooled HRs for DFS ranged from 1.89 to 3.44. Here, VEGFC is linked to breast cancer.